Related Experiment Video

Updated: Jul 18, 2026

Measuring Caenorhabditis elegans Life Span in 96 Well Microtiter Plates
12:23

Measuring Caenorhabditis elegans Life Span in 96 Well Microtiter Plates

Published on: March 18, 2011

Anticonvulsant medications extend worm life-span

Kimberley Evason1, Cheng Huang, Idella Yamben

  • 1Department of Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, MO 63110, USA.

Science (New York, N.Y.)
|January 18, 2005
PubMed

Insights

Certain anticonvulsant drugs, including ethosuximide and trimethadione, were found to extend the lifespan and delay aging in Caenorhabditis elegans. This suggests neural activity may play a key role in the aging process.

Area of Science:

  • Gerontology
  • Neuroscience
  • Pharmacology

Background:

  • Genetic research has identified aging mechanisms, but drug development for aging delay remains limited.
  • Identifying interventions that slow aging is crucial for improving healthspan and longevity.

Purpose of the Study:

  • To investigate the potential of small molecules, specifically anticonvulsants, to modulate the aging process.
  • To determine if compounds affecting neural activity can extend lifespan and physiological function in aging organisms.

Main Methods:

  • Utilized the model organism Caenorhabditis elegans to assess lifespan and physiological decline.
  • Administered ethosuximide, trimethadione, and 3,3-diethyl-2-pyrrolidinone to evaluate their effects on aging parameters.
  • Monitored lifespan extension and the delay of age-related physiological deterioration.

Main Results:

  • Ethosuximide, trimethadione, and 3,3-diethyl-2-pyrrolidinone significantly increased mean and maximum lifespan in C. elegans.
  • These compounds also delayed age-related declines in physiological processes, indicating a retardation of the aging process.
  • The tested anticonvulsants modulated neuromuscular activity in nematodes.

Conclusions:

  • The anticonvulsant drugs ethosuximide and trimethadione extend lifespan and slow aging in C. elegans.
  • These findings suggest a link between anticonvulsant activity, neural modulation, and lifespan extension.
  • Neural activity is implicated as a potential regulator of the aging process.

More Related Videos

A Simple Method for High Throughput Chemical Screening in Caenorhabditis Elegans08:49

A Simple Method for High Throughput Chemical Screening in Caenorhabditis Elegans

Published on: March 20, 2018

Surveying Low-Cost Methods to Measure Lifespan and Healthspan in Caenorhabditis elegans10:08

Surveying Low-Cost Methods to Measure Lifespan and Healthspan in Caenorhabditis elegans

Published on: May 18, 2022

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Enhanced Elimination of Poison01:26

Enhanced Elimination of Poison

Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration01:23

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration

Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s half-life.
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...